Entity

Basecamp

Basecamp is an AI-based drug developer that uses artificial intelligence to discover and develop new medicines.

Why it’s in the news: It is in the news for raising $140 million in funding, which valued the company at $800 million.

Latest on Basecamp

  • AI-based drug developer Basecamp valued at $800 million after $140 million funding round

Connections

4 entities linked to Basecamp across the news graph.

Also connected to (4)